Filippo Marino, Francesco Rossi and Emilio Sacco (2023) “Mirabegron, a First-in-class Non-antimuscarinic Drug for the Overactive Bladder”, Novel Research Aspects in Medicine and Medical Science Vol. 8, pp. 48–67. doi: 10.9734/bpi/nramms/v8/9482F.